莱美药业：控股股东拟公开转让持有的2.47亿股

大河财立方12-12

【大河财立方消息】12月12日，莱美药业公告，控股股东广西梧州中恒集团股份有限公司拟通过公开征集受让方的方式协议转让持有的公司2.47亿股无限售条件流通股A股股票，占总股本的23.43%，转让价格不低于4.42元/股。目前，中恒集团直接持有公司2.47亿股，占总股本的23.43％；通过控股子公司南宁中恒同德医药产业投资基金合伙企业（有限合伙）持有公司2144.78万A股，占总股本的2.03％；此外...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2491339222?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-12 18:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2491339222","market":"sh","top_or_hot":-1,"title":"莱美药业：控股股东拟公开转让持有的2.47亿股","media":"大河财立方","content":"<div>\n<p>【大河财立方消息】12月12日，莱美药业公告，控股股东广西梧州中恒集团股份有限公司拟通过公开征集受让方的方式协议转让持有的公司2.47亿股无限售条件流通股A股股票，占总股本的23.43%，转让价格不低于4.42元/股。目前，中恒集团直接持有公司2.47亿股，占总股本的23.43％；通过控股子公司南宁中恒同德医药产业投资基金合伙企业（有限合伙）持有公司2144.78万A股，占总股本的2.03％；此外...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212183751ab722c82&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>莱美药业：控股股东拟公开转让持有的2.47亿股</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n莱美药业：控股股东拟公开转让持有的2.47亿股\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-12 18:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212183751ab722c82&s=b><strong>大河财立方</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>【大河财立方消息】12月12日，莱美药业公告，控股股东广西梧州中恒集团股份有限公司拟通过公开征集受让方的方式协议转让持有的公司2.47亿股无限售条件流通股A股股票，占总股本的23.43%，转让价格不低于4.42元/股。目前，中恒集团直接持有公司2.47亿股，占总股本的23.43％；通过控股子公司南宁中恒同德医药产业投资基金合伙企业（有限合伙）持有公司2144.78万A股，占总股本的2.03％；此外...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212183751ab722c82&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0012","symbol_name":"证金概念","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212183751ab722c82&s=b","article_id":"2491339222","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212183751ab722c82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2491339222","pubTimestamp":1733999496,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"12月12日，莱美药业公告，控股股东广西梧州中恒集团股份有限公司拟通过公开征集受让方的方式协议转让持有的公司2.47亿股无限售条件流通股A股股票，占总股本的23.43%，转让价格不低于4.42元/股。莱美药业表示，本次公开征集转让的实施可能导致公司控股股东和实际控制人发生变更。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300006":"莱美药业","600252":"中恒集团","BK0012":"证金概念","BK0239":"医药制造","BK0077":"质押式回购","BK0015":"沪股通50","BK0028":"国家队","BK0070":"员工持股","BK0188":"融资融券"},"translate_title":"Laimei Pharmaceutical: The controlling shareholder intends to publicly transfer 247 million shares held","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300006":1,"600252":0.9},"content_text":"【大河财立方消息】12月12日，莱美药业公告，控股股东广西梧州中恒集团股份有限公司拟通过公开征集受让方的方式协议转让持有的公司2.47亿股无限售条件流通股A股股票，占总股本的23.43%，转让价格不低于4.42元/股。目前，中恒集团直接持有公司2.47亿股，占总股本的23.43％；通过控股子公司南宁中恒同德医药产业投资基金合伙企业（有限合伙）持有公司2144.78万A股，占总股本的2.03％；此外，中恒集团的一致行动人广西广投国宏健康产业基金合伙企业（有限合伙）持有公司1111.11万股，占总股本的1.05％。莱美药业表示，本次公开征集转让的实施可能导致公司控股股东和实际控制人发生变更。责编:史健 | 审核:李震 | 监审:万军伟","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2491339222"}